Abbott Laboratories (ABT)
$103.72
0.00 (0.00%)
ABT Stock Quote Delayed 30 Minutes
9 Medical Devices Stocks to Buy Now
The grades of nine Medical Devices stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an "A" ("strong buy") or "B" overall ("buy") rating.
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
181.61B
PE Ratio
32.31
EPS
3.21
Volume (Avg. Vol.)
Day's Range
-
52-Week Range
$89.67 - $121.64
Dividend & Yield
$2.04 (1.97%)
ABT Stock Predictions, Articles, and Abbott Laboratories News
Spinoff Mania Is Winding Down (And Good Riddance!)
Sooner rather than later, investors will wake up to the reality of the spinoff boom: These deals aren't all "unlocking value."
ETF Alternatives for Last Week’s Hot Stocks
Some of InvestorPlace's top stock picks in energy, dividend, pharmaceutical, home furnishings and financial stocks can be wrapped up into exchange-traded funds.
Which Abbott Is the One to Own Post-Split?
Both offer good prospects, but if you can choose just one, AbbVie -- which is the device and diagnostics side -- looks a tad more promising than the pharma arm.
From the Experts: 4 Stocks to Hold Forever
Forever may be a long time, but these stocks picked by our InvestorPlace experts are tried-and-true investments that you can count on for the long haul.
Here’s Why Johnson & Johnson is Undervalued
The share price of Johnson & Johnson looks to be overvalued until you dive into the numbers and look for one-time special items that hide true earnings value
Abbott Labs Worth Less Than Its Spinoff
Abbott Laboratories' spun-off drug business, AbbVie, is being valued at just more than $55 billion -- a few billion dollars more than ABT.
3 Dividend Stocks in the ‘Sweet Spot’
Fiscal cliff or not, income-producing stocks will remain key -- and your best bet is to find solid, fairly valued companies that can keep hiking payouts.
4 Attractive Biopharma Stocks of All Sizes
Biopharma is a high-growth niche in a defensive sector, but you need to balance risk with reward. Here are four hot biopharma stocks of different sizes.
Johnson & Johnson Is Undervalued — Here’s Why
Johnson & Johnson appears overvalued today based on earnings that don't take into account one-time charges. Look beyond the numbers to find the real value.
Housing Booms, Tech Breaks — Wednesday’s IP Market Recap
A four-year best in housing starts sent homebuilders upward and onward Wednesday, but the tech sector was slammed after poor reports from IBM and Intel.
Should I Buy Abbott Labs? 3 Pros, 3 Cons
Success in a drug regimen meant to treat hepatitis C is buoying shares of Abbott Laboratories, but has the easy money in ABT shares already been made?
Stocks Rise on Good Economic News — Monday’s IP Market Recap
Better-than-expected retail sales and good news out of China helped move equities higher, erasing some of the losses from last week's dismal performance.
Woman’s $180 Stock Buy Balloons to $7M
Sometimes buy and hold REALLY does pay off. The late Grace Groner's purchase of three Abbott Labs shares in 1935 worked out well.
7 Companies Paying Their CEOs More Than the Taxman
These CEOs made more in 2011 than their companies paid in federal income tax.
What to Do When Your Dividend Stock Spins Off a Business
Wondering what'll happen to your dividends when Abbott, Kraft and United Online execute spinoffs later this year? Here's what to expect.
New Heart Attack Test Could Save Time, Money in ER
Researchers say a new screening technology could help doctors diagnose a heart attack in as little as one hour.
How to Pick the Best High-Yield Stocks in Big Pharma
Big Pharma is a great place to find yield, and health care is a sure-fire long-term bet. But rather than shake a stick at this sector, go ahead ... be picky.
Pharma’s Q2 Earnings Lesson: The Big Picture Looks Good
The promising signs coming out of pharma this quarter doesn't mean you can just pick a stock out of a hat -- but it does mean a few are worth picking.
This New ETF Revolves Around Rotation
The lone new ETF last week, U.S. Equity Rotation Strategy, will shift its holdings among sectors according to the fund managers' view of the markets.
